InvestSMART

Universal Biosensors, Inc. (ASX: UBI) - Announcements

DELISTED - Current share price for UBI : $0.014

ASX company news and announcements for Universal Biosensors, Inc. (UBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Universal Biosensors, Inc. (UBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Universal Biosensors, Inc. (UBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Universal Biosensors, Inc. (UBI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Proposed issue of securities - UBI 1 Mar 2024 3:53PM $0.150 $0.014 fallen by 90.67%
$4 Notification of cessation of securities - UBI 1 Mar 2024 3:52PM $0.150 $0.014 fallen by 90.67%
$4 FY2023 Results Presentation 1 Mar 2024 9:16AM $0.160 $0.014 fallen by 91.25%
$4 Intention to raise capital 1 Mar 2024 9:13AM $0.160 $0.014 fallen by 91.25%
$4 FY2023 Corporate Governance Statement and Appendix 4G 29 Feb 2024 3:53PM $0.160 $0.014 fallen by 91.25%
$4 Appendix 4E and Annual Report on Form 10-K FY2023 29 Feb 2024 3:53PM $0.160 $0.014 fallen by 91.25%
$4 December 2023 Quarterly Activity Report and Appendix 4C 31 Jan 2024 9:45AM $0.210 $0.014 fallen by 93.33%
$4 Notification regarding unquoted securities - UBI 8 Jan 2024 2:00PM $0.220 $0.014 fallen by 93.64%
$4 Notification of cessation of securities - UBI 4 Jan 2024 10:26AM $0.210 $0.014 fallen by 93.33%
$4 UBI Update 21 Dec 2023 11:14AM $0.190 $0.014 fallen by 92.63%
$4 Appendix 3Y - Graham McLean 12 Dec 2023 9:48AM $0.190 $0.014 fallen by 92.63%
$4 Change in substantial holding 8 Dec 2023 2:06PM $0.200 $0.014 fallen by 93%
$4 Universal Biosensors to host investor webinar and Q&A 31 Oct 2023 9:26AM $0.255 $0.014 fallen by 94.51%
$4 Q3 2023 Results Presentation - 30 September 2023 30 Oct 2023 12:36PM $0.250 $0.014 fallen by 94.40%
$4 Q3 2023 Results 30 Oct 2023 12:35PM $0.250 $0.014 fallen by 94.40%
$4 September 2023 Quarterly Activity Report and Appendix 4C 30 Oct 2023 12:29PM $0.250 $0.014 fallen by 94.40%
$4 Xprecia Prime 4U approved for Patient Self-Testing in Europe 4 Oct 2023 10:59AM $0.280 $0.014 fallen by 95%
$4 Change of Director's Interest Notice 13 Sep 2023 4:16PM $0.230 $0.014 fallen by 93.91%
$4 Approval and first order for Xprecia Prime in India 31 Aug 2023 8:28AM $0.240 $0.014 fallen by 94.17%
$4 UBI receives $4,495,137 under the R&D Tax Incentive Rebate 21 Aug 2023 12:09PM $0.240 $0.014 fallen by 94.17%
$4 Xprecia Prime tender win in Italy 9 Aug 2023 8:28AM $0.270 $0.014 fallen by 94.81%
$4 UBI Petrackr Update 8 Aug 2023 8:28AM $0.230 $0.014 fallen by 93.91%
$4 H1 2023 Results Webinar 2 Aug 2023 8:29AM $0.240 $0.014 fallen by 94.17%
$4 Half Year Results Presentation - 30 June 2023 31 Jul 2023 8:49AM $0.265 $0.014 fallen by 94.72%
$4 Appendix 4D and Half Year Results - 30 June 2023 31 Jul 2023 8:44AM $0.265 $0.014 fallen by 94.72%

101 - 125 of 640 results

Page 5 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.